Lenograstim Overview Categories 10 Drugs affecting the blood10.4 Anabolics & hematopoietics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Lenograstim Manufacturers of Lenograstim Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Lenograstim's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 150 ug/m2eter150 (150)24 hourlySC,IV InfStarted the day after transplantation /chemotherapy completion. Paedriatic Dosage (20kg) 19.2 million unit/sq metre35 (35)24 hourlyIV InfusionNot use more than 28 days .Dose recommended for paeds over 2 Yrs19.2 million/sq metre35 (35)24 hourlySubcutaneousNot use more than 28 days .Dose recommended for paeds over 2 Yrs . Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Lenograstim is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Lenograstim Back to top Manufacturers of Lenograstim in Pakistan Aventis Back to top Previous Drug Generic - Next Drug Generic
Lenograstim Overview Categories 10 Drugs affecting the blood10.4 Anabolics & hematopoietics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Lenograstim Manufacturers of Lenograstim Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Lenograstim's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 150 ug/m2eter150 (150)24 hourlySC,IV InfStarted the day after transplantation /chemotherapy completion. Paedriatic Dosage (20kg) 19.2 million unit/sq metre35 (35)24 hourlyIV InfusionNot use more than 28 days .Dose recommended for paeds over 2 Yrs19.2 million/sq metre35 (35)24 hourlySubcutaneousNot use more than 28 days .Dose recommended for paeds over 2 Yrs . Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Lenograstim is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Lenograstim Back to top Manufacturers of Lenograstim in Pakistan Aventis Back to top Previous Drug Generic - Next Drug Generic